|
US4954526A
(en)
*
|
1989-02-28 |
1990-09-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
|
|
US5039705A
(en)
*
|
1989-09-15 |
1991-08-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
|
|
US5212204A
(en)
*
|
1989-10-18 |
1993-05-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antihypertensive compositions and use thereof
|
|
US5155137A
(en)
*
|
1990-09-20 |
1992-10-13 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Complexes of nitric oxide with polyamines
|
|
US5268465A
(en)
*
|
1991-01-18 |
1993-12-07 |
The Johns Hopkins University |
Purification and molecular cloning of nitric oxide synthase
|
|
US5339705A
(en)
|
1991-03-07 |
1994-08-23 |
Nissan Motor Co., Ltd. |
Shift device for automatic transmission
|
|
US5380758A
(en)
*
|
1991-03-29 |
1995-01-10 |
Brigham And Women's Hospital |
S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
|
|
AU668107B2
(en)
*
|
1991-09-24 |
1996-04-26 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services, The |
Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
|
|
US5910316A
(en)
*
|
1992-08-24 |
1999-06-08 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Use of nitric oxide-releasing agents to treat impotency
|
|
US5525357A
(en)
*
|
1992-08-24 |
1996-06-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
|
US5650447A
(en)
*
|
1992-08-24 |
1997-07-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Nitric oxide-releasing polymers to treat restenosis and related disorders
|
|
US5405919A
(en)
*
|
1992-08-24 |
1995-04-11 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
|
|
US5632981A
(en)
|
1992-08-24 |
1997-05-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
|
EP0670902A1
(en)
*
|
1992-11-25 |
1995-09-13 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
cDNA CLONE FOR HUMAN INDUCIBLE NITRIC OXYDE SYNTHASE AND PROCESS FOR PREPARING SAME
|
|
US5658565A
(en)
*
|
1994-06-24 |
1997-08-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Inducible nitric oxide synthase gene for treatment of disease
|
|
JPH08507715A
(ja)
*
|
1993-03-18 |
1996-08-20 |
シーダーズ サイナイ メディカル センター |
生体人工部材のための薬剤導入性および放出性重合性コーティング
|
|
US5428070A
(en)
*
|
1993-06-11 |
1995-06-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
|
|
US5891459A
(en)
*
|
1993-06-11 |
1999-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
|
|
US5945452A
(en)
*
|
1993-06-11 |
1999-08-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
|
|
US6087479A
(en)
*
|
1993-09-17 |
2000-07-11 |
Nitromed, Inc. |
Localized use of nitric oxide-adducts to prevent internal tissue damage
|
|
US5362718A
(en)
*
|
1994-04-18 |
1994-11-08 |
American Home Products Corporation |
Rapamycin hydroxyesters
|
|
US5583101A
(en)
*
|
1994-07-15 |
1996-12-10 |
Harvard College |
Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction
|
|
US5665077A
(en)
*
|
1995-04-24 |
1997-09-09 |
Nitrosci Pharmaceuticals Llc |
Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
|
|
US6232434B1
(en)
*
|
1996-08-02 |
2001-05-15 |
Duke University Medical Center |
Polymers for delivering nitric oxide in vivo
|
|
CA2263647C
(en)
*
|
1996-08-21 |
2011-02-15 |
Zofia J. Chrzan |
Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds
|
|
EP2292630B1
(en)
*
|
1996-09-27 |
2015-11-25 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates
|
|
CA2293501A1
(en)
*
|
1997-07-03 |
1999-01-14 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Nitric oxide-releasing amidine-derived diazeniumdiolates, compositions and uses thereof
|
|
US6015815A
(en)
*
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
US7378105B2
(en)
*
|
1997-09-26 |
2008-05-27 |
Abbott Laboratories |
Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens
|
|
GB9801398D0
(en)
*
|
1998-01-22 |
1998-03-18 |
Anggard Erik E |
Chemical compounds
|
|
ES2212821T3
(es)
|
1998-03-26 |
2004-08-01 |
Biomat B.V. |
Extensores endovasculares con revestimiento polimerico.
|
|
US6299980B1
(en)
|
1998-09-29 |
2001-10-09 |
Medtronic Ave, Inc. |
One step lubricious coating
|
|
JP2003506142A
(ja)
|
1999-08-04 |
2003-02-18 |
シー・アール・バード・インク |
一酸化窒素を放出する医療用装置
|
|
US6737447B1
(en)
*
|
1999-10-08 |
2004-05-18 |
The University Of Akron |
Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
|
|
US7416559B2
(en)
*
|
2000-10-27 |
2008-08-26 |
Poly-Med, Inc. |
Micromantled drug-eluting stent
|
|
US6706274B2
(en)
*
|
2001-01-18 |
2004-03-16 |
Scimed Life Systems, Inc. |
Differential delivery of nitric oxide
|
|
US6841166B1
(en)
*
|
2001-08-21 |
2005-01-11 |
The Regents Of The University Of Michigan |
Nitric oxide-releasing polymers incorporating diazeniumdiolated silane derivatives
|
|
US6673338B1
(en)
*
|
2001-09-10 |
2004-01-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing imidate and thioimidate diazeniumdiolates, compositions, uses thereof and method of making same
|
|
US6703046B2
(en)
|
2001-10-04 |
2004-03-09 |
Medtronic Ave Inc. |
Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
|
|
US7919075B1
(en)
|
2002-03-20 |
2011-04-05 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices
|
|
US7070798B1
(en)
*
|
2002-06-21 |
2006-07-04 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
|
|
US6949530B2
(en)
*
|
2002-07-18 |
2005-09-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
|
|
EP1545798A4
(en)
*
|
2002-08-02 |
2006-06-14 |
Us Gov Health & Human Serv |
NETWORKED NITROGEN OXIDE RELEASING POLYAMINE-COATED SUBSTRATES, THESE COMPOSITIONS AND MANUFACTURING PROCESSES DAF R
|
|
US6951902B2
(en)
*
|
2002-08-16 |
2005-10-04 |
Michigan Biotechnology Institute |
Two dimensional polymer that generates nitric oxide
|
|
US20040180131A1
(en)
*
|
2003-03-14 |
2004-09-16 |
Medtronic Ave. |
Stent coating method
|
|
EP1691856A2
(en)
|
2003-10-14 |
2006-08-23 |
Cube Medical A/S |
Medical device with electrospun nanofibers
|
|
US8528599B2
(en)
*
|
2003-11-26 |
2013-09-10 |
Borgwarner Inc. |
Pulse width modulated solenoid
|
|
US20050171596A1
(en)
*
|
2004-02-03 |
2005-08-04 |
Furst Joseph G. |
Stents with amphiphilic copolymer coatings
|
|
US7569559B2
(en)
*
|
2004-02-09 |
2009-08-04 |
Noxilizer, Inc. |
Nitric oxide-releasing molecules
|
|
US7829553B2
(en)
|
2004-02-09 |
2010-11-09 |
Amulet Pharmaceuticals, Inc. |
Nitric oxide-releasing polymers
|
|
WO2005112954A1
(en)
*
|
2004-05-14 |
2005-12-01 |
William Marsh Rice University |
Nitric oxide releasing compositions and associated methods
|
|
WO2005115489A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Genzyme Corporation |
Adherent polymeric compositions
|
|
US20060008529A1
(en)
*
|
2004-07-12 |
2006-01-12 |
Meyerhoff Mark E |
Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
|
|
EP1794195B1
(en)
|
2004-09-27 |
2014-12-17 |
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services |
Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof
|
|
US20060099235A1
(en)
*
|
2004-11-11 |
2006-05-11 |
Medtronic Vascular, Inc. |
Medical devices and compositions useful for treating or inhibiting restenosis
|
|
US20060251824A1
(en)
*
|
2005-05-05 |
2006-11-09 |
Boulais Dennis R |
Coating of medical devices with solids
|
|
EP1933845A2
(en)
|
2005-08-25 |
2008-06-25 |
Medtronic Vascular, Inc. |
Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore
|
|
US20070053952A1
(en)
*
|
2005-09-07 |
2007-03-08 |
Medtronic Vascular, Inc. |
Nitric oxide-releasing polymers derived from modified polymers
|
|
CA2628055C
(en)
|
2005-10-31 |
2013-10-01 |
Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services |
Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
|
|
WO2007053578A2
(en)
|
2005-10-31 |
2007-05-10 |
Amulet Pharmaceuticals, Inc. |
Multi-phasic nitric oxide and drug co-eluting stent coatings
|
|
AU2007212501B2
(en)
*
|
2006-02-07 |
2011-03-31 |
Tepha, Inc. |
Polymeric, degradable drug-eluting stents and coatings
|
|
US8241619B2
(en)
*
|
2006-05-15 |
2012-08-14 |
Medtronic Vascular, Inc. |
Hindered amine nitric oxide donating polymers for coating medical devices
|
|
US8339735B2
(en)
*
|
2007-06-29 |
2012-12-25 |
Seagate Technology Llc |
Magnetic writer for patterned stack with increased write field
|
|
US8273828B2
(en)
|
2007-07-24 |
2012-09-25 |
Medtronic Vascular, Inc. |
Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation
|
|
US20090222088A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Medtronic Vascular, Inc. |
Secondary Amine Containing Nitric Oxide Releasing Polymer Composition
|
|
US20090232863A1
(en)
*
|
2008-03-17 |
2009-09-17 |
Medtronic Vascular, Inc. |
Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers
|
|
US20090232868A1
(en)
*
|
2008-03-17 |
2009-09-17 |
Medtronic Vascular, Inc. |
Nitric Oxide Releasing Polymer Composition
|